3.82 USD
↘ 0.35 (8.39%)AT CLOSE (11:59 AM EDT)
AN2 Therapeutics, Inc. Common Stock
ANTXNASDAQ • USD
3.81
↘ 0.01 (0.34%)
POST MARKET (AS OF 07:57 PM EDT)
Post Market
AS OF 07:57 PM EDT
3.81
↘ 0.01 (0.34%)
Market: CLOSED
Open?$4.19
High?$4.19
Low?$3.75
Prev. Close?$4.17
Volume?178.2K
Avg. Volume?239.2K
VWAP?$3.91
Rel. Volume?0.74x
Bid / Ask
Bid?$3.31 × 300
Ask?$4.30 × 500
Spread?$0.99
Midpoint?$3.80
Valuation & Ratios
Market Cap?137.6M
Shares Out?36.0M
Float?25.9M
Float %?72.2%
P/E Ratio?N/A
P/B Ratio?1.68
EPS?-$0.96
Dividend?0.00%
Ex-Dividend?N/A
Shares of AN2 Therapeutics, Inc. Common Stock (ANTX) are trading at $3.82. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, ANTX appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
Themes
Employees
21
Market Cap
137.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2022-03-25
Address
1300 EL CAMINO REAL, SUITE 100
MENLO PARK, CA 94025
Phone: (650) 331-9090
MENLO PARK, CA 94025
Phone: (650) 331-9090
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?69
Piotroski F-Score?0/9Weak
Altman Z-Score?10.11Safe
Confidence?40%Low
Short InterestModerate
Short % of Float?3.22%Low
Short Interest?836.4K
Days to Cover?3.5
Free Float25.9M
Avg Daily Volume240.7K
Settlement Date2026-05-15
Financial Health
Current Ratio?15.73Strong
Quick Ratio?15.73Strong
Cash Ratio?9.62Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.68CHEAP▾
Peers100
S&P83
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-2.3CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-42.3%WEAK▾
S&P3
ROA?-39.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$84.1M
Fundamentals ratios updated end of day